Clinical Trial Update: Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of HRS-1893 tablets in healthy subjects and those with impaired kidney function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Hypertrophic Cardiomyopathy | Phase 1 | Status: COMPLETED